Wellington Management Group
SMMT icon

Wellington Management Group’s Summit Therapeutics SMMT Stock Holding History

Wellington Management Group’s Portfolio SMMT Stock Details SMMT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$6.88M Buy
+362,858
New +$5.87M ﹤0.01% 1339
2025
Q3 		– Sell
-39,694
Closed -$845K – 2093
2025
Q2 		$845K Sell
39,694
-798
-2% -$18.2K ﹤0.01% 1744
2025
Q1 		$781K Buy
40,492
+373
+0.9% +$7.48K ﹤0.01% 1759
2024
Q4 		$716K Sell
40,119
-4,069
-9% -$78.9K ﹤0.01% 1782
2024
Q3 		$968K Sell
44,188
-223,964
-84% -$3.13M ﹤0.01% 1716
2024
Q2 		$2.09M Sell
268,152
-29,468
-10% -$159K ﹤0.01% 1504
2024
Q1 		$1.23M Buy
+297,620
New +$1.18M ﹤0.01% 1631

Other funds holding SMMT

BBA
Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return

Wellington Management Group's SMMT Position: Q1 2026 in Review

Wellington Management Group opened a new position in Summit Therapeutics (SMMT) in Q1 2026: 362,858 shares worth $6.88M. The stake represents ﹤0.01% of the portfolio and ranks #1339 among its holdings. This is a return to the name: Wellington Management Group previously reported a position in SMMT as recently as Q2 2025.

Wellington Management Group first reported a position in SMMT in Q1 2024 and has held it in 7 quarters since. 222 funds tracked by Wall St. Rank hold SMMT as of Q1 2026.

  • Wellington Management Group held 362,858 shares of Summit Therapeutics worth $6.88M as of Q1 2026.
  • Summit Therapeutics was a new Wellington Management Group position in Q1 2026.
  • Summit Therapeutics made up ﹤0.01% of Wellington Management Group's portfolio in Q1 2026, its #1339 holding.
  • Wellington Management Group first reported a position in Summit Therapeutics in Q1 2024 and has held it in 7 quarters since.
  • 222 funds tracked by Wall St. Rank held Summit Therapeutics as of Q1 2026.

Based on Wellington Management Group's 13F filing for Q1 2026, filed 15 May 2026.